CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer

<p>Abstract</p> <p>Background</p> <p>Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC). CA 15-3 measures the protein product of the MUC1 gene and is the most widely used serum marker in breast cancer.</p> <p>Methods<...

Full description

Bibliographic Details
Main Authors: McDermott Enda W, Myers Eddie, Kelly Gabrielle, Al-azawi Dhafir, Hill Arnold DK, Duffy Michael J, Higgins Niall O
Format: Article
Language:English
Published: BMC 2006-09-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/6/220